Navigation Links
Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1
Date:2/23/2011

PALO ALTO, Calif., Feb. 23, 2011 /PRNewswire/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company will make a presentation at the Citi 2011 Global Health Care Conference in New York on Tuesday, March 1, 2011 at 9:30 a.m. Eastern Time.  Bruce Cozadd, the company's chairman and chief executive officer, will provide a business update.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of the webcast will be available for at least one week on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
2. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
3. Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
4. Avanir Pharmaceuticals to Present at Three Conferences in March
5. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
6. Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
7. Isis Pharmaceuticals to Present at the 2011 Citi Global Healthcare Conference
8. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
9. MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
10. Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV)
11. Dr. Abraham Abuchowski of Prolong Pharmaceuticals Honored With Inaugural Tibbetts Award by the U.S. Small Business Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... 10, 2017 The Institute for In Vitro ... the recipient of a VITROCELL® inhalation exposure system thanks ... Consortium. The device, which is designed to replace animals ... lung cells to airborne test materials in an environment ... VITROCELL® system for testing combustible tobacco products, as well ...
(Date:7/5/2017)... -- Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials proves ... to progress molecular radiotherapy imaging. In molecular radiotherapy ... accurately quantify the radiation absorbed by those patients undergoing treatment. ... this radiotherapy treatment has been available — that is, until ... ...
Breaking Medicine Technology:
(Date:7/20/2017)... , ... July 20, 2017 , ... The Dermatology Clinic ... Dr. Dunbar received his BS in Biology from LSU, graduating summa cum laude. He ... Class President. After his residency in St. Louis, Dr. Dunbar moved to New York ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Business Architecture ... of Knowledge (BIZBOK® Guide )v 6.0 is now available for member download. This ... Guild collaborative teams. , Non-members may download the Part 1 Introduction for ...
(Date:7/20/2017)... ... July 20, 2017 , ... LINET, an international leader in healthcare technology and ... the AVE 2 birthing bed. , Perfectly suitable for labor, delivery, recovery and postpartum; ... and efficiency to every phase of childbirth. The AVE 2 has many features that ...
(Date:7/20/2017)... Waco, TX (PRWEB) , ... July 19, 2017 , ... ... announce the availability of temporomandibular joint (TMJ) treatment and dental implants in ... the TRIOS® intraoral scanner and the T-Scan™ by Tekscan®, they can capture details in ...
(Date:7/20/2017)... ... 19, 2017 , ... Adolfson & Peterson Construction (AP) continues ... As a leader in healthcare construction, AP has successfully built several well-known medical ... Midwest with Josh now on board. , Josh brings over nine years ...
Breaking Medicine News(10 mins):